Metabolic PCTA-Based Shift Reagents for the Detection of Extracellular Lactate Using CEST MRI.
Ontology highlight
ABSTRACT: Lactate is a key metabolic driver in oncology and immunology. Even in the presence of physiological oxygen levels, most cancer cells upregulate anaerobic glycolysis, resulting in abnormal lactate production and accumulation in the tumor microenvironment. The development of more effective, sensitive, and safe probes for detecting extracellular lactate holds the potential to significantly impact cancer metabolic profiling and staging significantly. Macrocyclic-based PARACEST agents have been reported to act as shift reagents (SRs) and detect extracellular lactate via chemical exchange saturation transfer (CEST) MRI. Here, we introduce a new family of SRs based on the PCTA ligand, an inherently stable and kinetically inert group of molecules with the potential for (pre)clinical translation. W
SUBMITTER: Chiaffarelli R
PROVIDER: S-EPMC11862947 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA